nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—PDE3A—penis—prostate cancer	0.0605	0.296	CbGeAlD
Levosimendan—TNNC1—prostate gland—prostate cancer	0.0241	0.118	CbGeAlD
Levosimendan—KCNJ8—prostate gland—prostate cancer	0.0181	0.0884	CbGeAlD
Levosimendan—KCNJ8—seminal vesicle—prostate cancer	0.0153	0.0748	CbGeAlD
Levosimendan—PDE3A—prostate gland—prostate cancer	0.0145	0.0706	CbGeAlD
Levosimendan—KCNJ8—renal system—prostate cancer	0.0123	0.0603	CbGeAlD
Levosimendan—KCNJ8—urethra—prostate cancer	0.0121	0.0592	CbGeAlD
Levosimendan—TNNC1—testis—prostate cancer	0.0106	0.0519	CbGeAlD
Levosimendan—KCNJ8—testis—prostate cancer	0.00798	0.039	CbGeAlD
Levosimendan—TNNC1—lymph node—prostate cancer	0.00771	0.0376	CbGeAlD
Levosimendan—PDE3A—testis—prostate cancer	0.00637	0.0311	CbGeAlD
Levosimendan—KCNJ8—lymph node—prostate cancer	0.00578	0.0282	CbGeAlD
Levosimendan—KCNJ11—lymph node—prostate cancer	0.00471	0.023	CbGeAlD
Levosimendan—PDE3A—lymph node—prostate cancer	0.00462	0.0225	CbGeAlD
Levosimendan—Cardiac disorder—Estradiol valerate/Dienogest—prostate cancer	0.00393	0.00776	CcSEcCtD
Levosimendan—Cardiac disorder—Degarelix—prostate cancer	0.00374	0.00738	CcSEcCtD
Levosimendan—Mental disorder—Estradiol valerate/Dienogest—prostate cancer	0.00371	0.00733	CcSEcCtD
Levosimendan—Malnutrition—Estradiol valerate/Dienogest—prostate cancer	0.00369	0.00728	CcSEcCtD
Levosimendan—Angiopathy—Degarelix—prostate cancer	0.00365	0.00722	CcSEcCtD
Levosimendan—Mental disorder—Degarelix—prostate cancer	0.00353	0.00697	CcSEcCtD
Levosimendan—Cardiac disorder—Cabazitaxel—prostate cancer	0.00352	0.00695	CcSEcCtD
Levosimendan—Malnutrition—Degarelix—prostate cancer	0.00351	0.00692	CcSEcCtD
Levosimendan—Angiopathy—Cabazitaxel—prostate cancer	0.00344	0.0068	CcSEcCtD
Levosimendan—Cardiac failure—Goserelin—prostate cancer	0.00335	0.00662	CcSEcCtD
Levosimendan—Haemoglobin decreased—Docetaxel—prostate cancer	0.00334	0.00661	CcSEcCtD
Levosimendan—Mental disorder—Cabazitaxel—prostate cancer	0.00332	0.00656	CcSEcCtD
Levosimendan—Malnutrition—Cabazitaxel—prostate cancer	0.0033	0.00652	CcSEcCtD
Levosimendan—Insomnia—Estramustine—prostate cancer	0.00326	0.00645	CcSEcCtD
Levosimendan—Haemoglobin decreased—Capecitabine—prostate cancer	0.00324	0.00639	CcSEcCtD
Levosimendan—Insomnia—Abiraterone—prostate cancer	0.00317	0.00626	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Abiraterone—prostate cancer	0.00303	0.00598	CcSEcCtD
Levosimendan—Cardiac disorder—Bicalutamide—prostate cancer	0.00302	0.00596	CcSEcCtD
Levosimendan—Constipation—Abiraterone—prostate cancer	0.003	0.00592	CcSEcCtD
Levosimendan—Angiopathy—Bicalutamide—prostate cancer	0.00295	0.00583	CcSEcCtD
Levosimendan—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.00295	0.00583	CcSEcCtD
Levosimendan—Hypokalaemia—Conjugated Estrogens—prostate cancer	0.00295	0.00583	CcSEcCtD
Levosimendan—Ventricular fibrillation—Capecitabine—prostate cancer	0.00291	0.00575	CcSEcCtD
Levosimendan—Insomnia—Nilutamide—prostate cancer	0.0029	0.00572	CcSEcCtD
Levosimendan—Insomnia—Flutamide—prostate cancer	0.00288	0.00569	CcSEcCtD
Levosimendan—Myocardial ischaemia—Docetaxel—prostate cancer	0.00286	0.00565	CcSEcCtD
Levosimendan—Mental disorder—Bicalutamide—prostate cancer	0.00285	0.00563	CcSEcCtD
Levosimendan—Malnutrition—Bicalutamide—prostate cancer	0.00283	0.00559	CcSEcCtD
Levosimendan—Nervous system disorder—Degarelix—prostate cancer	0.00281	0.00554	CcSEcCtD
Levosimendan—Myocardial ischaemia—Capecitabine—prostate cancer	0.00277	0.00547	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Nilutamide—prostate cancer	0.00276	0.00546	CcSEcCtD
Levosimendan—Constipation—Nilutamide—prostate cancer	0.00274	0.00541	CcSEcCtD
Levosimendan—Constipation—Flutamide—prostate cancer	0.00273	0.00538	CcSEcCtD
Levosimendan—Hypotension—Degarelix—prostate cancer	0.00267	0.00528	CcSEcCtD
Levosimendan—Extrasystoles—Capecitabine—prostate cancer	0.00265	0.00523	CcSEcCtD
Levosimendan—Nervous system disorder—Cabazitaxel—prostate cancer	0.00264	0.00522	CcSEcCtD
Levosimendan—Tachycardia—Cabazitaxel—prostate cancer	0.00263	0.00519	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.0026	0.00513	CcSEcCtD
Levosimendan—Insomnia—Degarelix—prostate cancer	0.00259	0.00511	CcSEcCtD
Levosimendan—Hypotension—Cabazitaxel—prostate cancer	0.00252	0.00497	CcSEcCtD
Levosimendan—Angiopathy—Ethinyl Estradiol—prostate cancer	0.0025	0.00493	CcSEcCtD
Levosimendan—Cardiac failure—Mitoxantrone—prostate cancer	0.00248	0.00489	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Degarelix—prostate cancer	0.00247	0.00488	CcSEcCtD
Levosimendan—Diarrhoea—Estramustine—prostate cancer	0.00247	0.00488	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Capecitabine—prostate cancer	0.00247	0.00487	CcSEcCtD
Levosimendan—Constipation—Degarelix—prostate cancer	0.00245	0.00483	CcSEcCtD
Levosimendan—Mental disorder—Ethinyl Estradiol—prostate cancer	0.00241	0.00476	CcSEcCtD
Levosimendan—Diarrhoea—Abiraterone—prostate cancer	0.0024	0.00474	CcSEcCtD
Levosimendan—Malnutrition—Ethinyl Estradiol—prostate cancer	0.00239	0.00473	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00233	0.00459	CcSEcCtD
Levosimendan—Constipation—Cabazitaxel—prostate cancer	0.0023	0.00455	CcSEcCtD
Levosimendan—Vomiting—Estramustine—prostate cancer	0.0023	0.00453	CcSEcCtD
Levosimendan—Dizziness—Estrone—prostate cancer	0.00228	0.0045	CcSEcCtD
Levosimendan—Nervous system disorder—Bicalutamide—prostate cancer	0.00227	0.00448	CcSEcCtD
Levosimendan—Headache—Estramustine—prostate cancer	0.00226	0.00447	CcSEcCtD
Levosimendan—Vomiting—Abiraterone—prostate cancer	0.00223	0.0044	CcSEcCtD
Levosimendan—Hypokalaemia—Mitoxantrone—prostate cancer	0.0022	0.00434	CcSEcCtD
Levosimendan—Vomiting—Estrone—prostate cancer	0.00219	0.00433	CcSEcCtD
Levosimendan—Diarrhoea—Nilutamide—prostate cancer	0.00219	0.00433	CcSEcCtD
Levosimendan—Diarrhoea—Flutamide—prostate cancer	0.00218	0.00431	CcSEcCtD
Levosimendan—Headache—Estrone—prostate cancer	0.00216	0.00427	CcSEcCtD
Levosimendan—Nausea—Estramustine—prostate cancer	0.00214	0.00423	CcSEcCtD
Levosimendan—Dizziness—Nilutamide—prostate cancer	0.00212	0.00418	CcSEcCtD
Levosimendan—Dizziness—Flutamide—prostate cancer	0.00211	0.00416	CcSEcCtD
Levosimendan—Cardiac disorder—Goserelin—prostate cancer	0.0021	0.00415	CcSEcCtD
Levosimendan—Insomnia—Bicalutamide—prostate cancer	0.00209	0.00413	CcSEcCtD
Levosimendan—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.00208	0.00411	CcSEcCtD
Levosimendan—Cardiac failure—Etoposide—prostate cancer	0.00206	0.00407	CcSEcCtD
Levosimendan—Angiopathy—Goserelin—prostate cancer	0.00205	0.00406	CcSEcCtD
Levosimendan—Nausea—Estrone—prostate cancer	0.00205	0.00404	CcSEcCtD
Levosimendan—Vomiting—Nilutamide—prostate cancer	0.00204	0.00402	CcSEcCtD
Levosimendan—Angiopathy—Conjugated Estrogens—prostate cancer	0.00203	0.00402	CcSEcCtD
Levosimendan—Vomiting—Flutamide—prostate cancer	0.00203	0.004	CcSEcCtD
Levosimendan—Headache—Nilutamide—prostate cancer	0.00201	0.00396	CcSEcCtD
Levosimendan—Headache—Flutamide—prostate cancer	0.002	0.00394	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.002	0.00394	CcSEcCtD
Levosimendan—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00199	0.00393	CcSEcCtD
Levosimendan—Mental disorder—Goserelin—prostate cancer	0.00198	0.00392	CcSEcCtD
Levosimendan—Constipation—Bicalutamide—prostate cancer	0.00198	0.0039	CcSEcCtD
Levosimendan—Malnutrition—Goserelin—prostate cancer	0.00197	0.00389	CcSEcCtD
Levosimendan—Mental disorder—Conjugated Estrogens—prostate cancer	0.00196	0.00388	CcSEcCtD
Levosimendan—Diarrhoea—Degarelix—prostate cancer	0.00196	0.00387	CcSEcCtD
Levosimendan—Malnutrition—Conjugated Estrogens—prostate cancer	0.00195	0.00385	CcSEcCtD
Levosimendan—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.00192	0.00378	CcSEcCtD
Levosimendan—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00191	0.00378	CcSEcCtD
Levosimendan—Nausea—Nilutamide—prostate cancer	0.0019	0.00376	CcSEcCtD
Levosimendan—Nausea—Flutamide—prostate cancer	0.00189	0.00374	CcSEcCtD
Levosimendan—Dizziness—Degarelix—prostate cancer	0.00189	0.00374	CcSEcCtD
Levosimendan—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00189	0.00372	CcSEcCtD
Levosimendan—Diarrhoea—Cabazitaxel—prostate cancer	0.00184	0.00364	CcSEcCtD
Levosimendan—Vomiting—Degarelix—prostate cancer	0.00182	0.00359	CcSEcCtD
Levosimendan—Headache—Degarelix—prostate cancer	0.00179	0.00354	CcSEcCtD
Levosimendan—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00179	0.00353	CcSEcCtD
Levosimendan—Dizziness—Cabazitaxel—prostate cancer	0.00178	0.00352	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—prostate cancer	0.00176	0.00348	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Epirubicin—prostate cancer	0.00172	0.00339	CcSEcCtD
Levosimendan—Vomiting—Cabazitaxel—prostate cancer	0.00171	0.00338	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—prostate cancer	0.00171	0.00338	CcSEcCtD
Levosimendan—Atrial fibrillation—Capecitabine—prostate cancer	0.00171	0.00337	CcSEcCtD
Levosimendan—Nausea—Degarelix—prostate cancer	0.0017	0.00336	CcSEcCtD
Levosimendan—Headache—Cabazitaxel—prostate cancer	0.00169	0.00333	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00169	0.00333	CcSEcCtD
Levosimendan—Constipation—Ethinyl Estradiol—prostate cancer	0.00167	0.0033	CcSEcCtD
Levosimendan—Cardiac disorder—Estradiol—prostate cancer	0.00167	0.00329	CcSEcCtD
Levosimendan—Cardiac failure—Capecitabine—prostate cancer	0.00166	0.00327	CcSEcCtD
Levosimendan—Angiopathy—Estradiol—prostate cancer	0.00163	0.00322	CcSEcCtD
Levosimendan—Nausea—Cabazitaxel—prostate cancer	0.0016	0.00316	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Doxorubicin—prostate cancer	0.00159	0.00314	CcSEcCtD
Levosimendan—Diarrhoea—Bicalutamide—prostate cancer	0.00158	0.00312	CcSEcCtD
Levosimendan—Nervous system disorder—Goserelin—prostate cancer	0.00158	0.00311	CcSEcCtD
Levosimendan—Mental disorder—Estradiol—prostate cancer	0.00157	0.0031	CcSEcCtD
Levosimendan—Tachycardia—Goserelin—prostate cancer	0.00157	0.0031	CcSEcCtD
Levosimendan—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.00156	0.00309	CcSEcCtD
Levosimendan—Malnutrition—Estradiol—prostate cancer	0.00156	0.00309	CcSEcCtD
Levosimendan—Tachycardia—Conjugated Estrogens—prostate cancer	0.00155	0.00307	CcSEcCtD
Levosimendan—Ventricular tachycardia—Epirubicin—prostate cancer	0.00155	0.00307	CcSEcCtD
Levosimendan—Dizziness—Bicalutamide—prostate cancer	0.00153	0.00302	CcSEcCtD
Levosimendan—Hypotension—Goserelin—prostate cancer	0.0015	0.00297	CcSEcCtD
Levosimendan—Hypotension—Conjugated Estrogens—prostate cancer	0.00149	0.00294	CcSEcCtD
Levosimendan—Cardiac failure—Prednisone—prostate cancer	0.00148	0.00292	CcSEcCtD
Levosimendan—Hypokalaemia—Capecitabine—prostate cancer	0.00147	0.00291	CcSEcCtD
Levosimendan—Vomiting—Bicalutamide—prostate cancer	0.00147	0.0029	CcSEcCtD
Levosimendan—Insomnia—Goserelin—prostate cancer	0.00145	0.00287	CcSEcCtD
Levosimendan—Headache—Bicalutamide—prostate cancer	0.00145	0.00286	CcSEcCtD
Levosimendan—Insomnia—Conjugated Estrogens—prostate cancer	0.00144	0.00285	CcSEcCtD
Levosimendan—Ventricular tachycardia—Doxorubicin—prostate cancer	0.00144	0.00284	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00138	0.00272	CcSEcCtD
Levosimendan—Constipation—Goserelin—prostate cancer	0.00138	0.00272	CcSEcCtD
Levosimendan—Nausea—Bicalutamide—prostate cancer	0.00137	0.00271	CcSEcCtD
Levosimendan—Constipation—Conjugated Estrogens—prostate cancer	0.00136	0.00269	CcSEcCtD
Levosimendan—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00134	0.00264	CcSEcCtD
Levosimendan—Hypokalaemia—Prednisone—prostate cancer	0.00131	0.00259	CcSEcCtD
Levosimendan—Dizziness—Ethinyl Estradiol—prostate cancer	0.00129	0.00255	CcSEcCtD
Levosimendan—Cardiac disorder—Etoposide—prostate cancer	0.00129	0.00255	CcSEcCtD
Levosimendan—Angiopathy—Etoposide—prostate cancer	0.00126	0.00249	CcSEcCtD
Levosimendan—Nervous system disorder—Estradiol—prostate cancer	0.00125	0.00247	CcSEcCtD
Levosimendan—Tachycardia—Estradiol—prostate cancer	0.00124	0.00246	CcSEcCtD
Levosimendan—Vomiting—Ethinyl Estradiol—prostate cancer	0.00124	0.00245	CcSEcCtD
Levosimendan—Headache—Ethinyl Estradiol—prostate cancer	0.00122	0.00242	CcSEcCtD
Levosimendan—Nausea—Ethinyl Estradiol—prostate cancer	0.00116	0.00229	CcSEcCtD
Levosimendan—Tachycardia—Mitoxantrone—prostate cancer	0.00116	0.00229	CcSEcCtD
Levosimendan—Cardiac failure—Epirubicin—prostate cancer	0.00115	0.00228	CcSEcCtD
Levosimendan—Insomnia—Estradiol—prostate cancer	0.00115	0.00228	CcSEcCtD
Levosimendan—Hypotension—Mitoxantrone—prostate cancer	0.00111	0.00219	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Estradiol—prostate cancer	0.0011	0.00217	CcSEcCtD
Levosimendan—Diarrhoea—Goserelin—prostate cancer	0.0011	0.00217	CcSEcCtD
Levosimendan—Constipation—Estradiol—prostate cancer	0.00109	0.00215	CcSEcCtD
Levosimendan—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00109	0.00215	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—prostate cancer	0.00107	0.00212	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—prostate cancer	0.00107	0.00211	CcSEcCtD
Levosimendan—Dizziness—Goserelin—prostate cancer	0.00106	0.0021	CcSEcCtD
Levosimendan—Dizziness—Conjugated Estrogens—prostate cancer	0.00105	0.00208	CcSEcCtD
Levosimendan—Angiopathy—Docetaxel—prostate cancer	0.00105	0.00207	CcSEcCtD
Levosimendan—Cardiac disorder—Capecitabine—prostate cancer	0.00104	0.00205	CcSEcCtD
Levosimendan—Hypokalaemia—Epirubicin—prostate cancer	0.00103	0.00203	CcSEcCtD
Levosimendan—Vomiting—Goserelin—prostate cancer	0.00102	0.00202	CcSEcCtD
Levosimendan—Constipation—Mitoxantrone—prostate cancer	0.00102	0.00201	CcSEcCtD
Levosimendan—Angiopathy—Capecitabine—prostate cancer	0.00102	0.00201	CcSEcCtD
Levosimendan—Vomiting—Conjugated Estrogens—prostate cancer	0.00101	0.002	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—prostate cancer	0.00101	0.002	CcSEcCtD
Levosimendan—Headache—Goserelin—prostate cancer	0.00101	0.00199	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—prostate cancer	0.00101	0.00199	CcSEcCtD
Levosimendan—Headache—Conjugated Estrogens—prostate cancer	0.000998	0.00197	CcSEcCtD
Levosimendan—Mental disorder—Capecitabine—prostate cancer	0.00098	0.00194	CcSEcCtD
Levosimendan—Malnutrition—Capecitabine—prostate cancer	0.000974	0.00192	CcSEcCtD
Levosimendan—Tachycardia—Etoposide—prostate cancer	0.000964	0.0019	CcSEcCtD
Levosimendan—Nausea—Goserelin—prostate cancer	0.000955	0.00189	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—prostate cancer	0.000949	0.00187	CcSEcCtD
Levosimendan—Nausea—Conjugated Estrogens—prostate cancer	0.000946	0.00187	CcSEcCtD
Levosimendan—Hypotension—Etoposide—prostate cancer	0.000923	0.00182	CcSEcCtD
Levosimendan—Angiopathy—Prednisone—prostate cancer	0.000904	0.00179	CcSEcCtD
Levosimendan—Mental disorder—Prednisone—prostate cancer	0.000873	0.00172	CcSEcCtD
Levosimendan—Diarrhoea—Estradiol—prostate cancer	0.000872	0.00172	CcSEcCtD
Levosimendan—Malnutrition—Prednisone—prostate cancer	0.000868	0.00171	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Etoposide—prostate cancer	0.000853	0.00168	CcSEcCtD
Levosimendan—Constipation—Etoposide—prostate cancer	0.000845	0.00167	CcSEcCtD
Levosimendan—Dizziness—Estradiol—prostate cancer	0.000843	0.00167	CcSEcCtD
Levosimendan—Diarrhoea—Mitoxantrone—prostate cancer	0.000813	0.00161	CcSEcCtD
Levosimendan—Vomiting—Estradiol—prostate cancer	0.000811	0.0016	CcSEcCtD
Levosimendan—Nervous system disorder—Docetaxel—prostate cancer	0.000805	0.00159	CcSEcCtD
Levosimendan—Tachycardia—Docetaxel—prostate cancer	0.000802	0.00158	CcSEcCtD
Levosimendan—Headache—Estradiol—prostate cancer	0.000799	0.00158	CcSEcCtD
Levosimendan—Nervous system disorder—Capecitabine—prostate cancer	0.00078	0.00154	CcSEcCtD
Levosimendan—Tachycardia—Capecitabine—prostate cancer	0.000776	0.00153	CcSEcCtD
Levosimendan—Hypotension—Docetaxel—prostate cancer	0.000767	0.00152	CcSEcCtD
Levosimendan—Nausea—Estradiol—prostate cancer	0.000757	0.0015	CcSEcCtD
Levosimendan—Vomiting—Mitoxantrone—prostate cancer	0.000755	0.00149	CcSEcCtD
Levosimendan—Headache—Mitoxantrone—prostate cancer	0.000744	0.00147	CcSEcCtD
Levosimendan—Hypotension—Capecitabine—prostate cancer	0.000743	0.00147	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—prostate cancer	0.000743	0.00147	CcSEcCtD
Levosimendan—Cardiac disorder—Epirubicin—prostate cancer	0.000724	0.00143	CcSEcCtD
Levosimendan—Insomnia—Capecitabine—prostate cancer	0.000719	0.00142	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000709	0.0014	CcSEcCtD
Levosimendan—Angiopathy—Epirubicin—prostate cancer	0.000707	0.0014	CcSEcCtD
Levosimendan—Nausea—Mitoxantrone—prostate cancer	0.000706	0.00139	CcSEcCtD
Levosimendan—Constipation—Docetaxel—prostate cancer	0.000702	0.00139	CcSEcCtD
Levosimendan—Nervous system disorder—Prednisone—prostate cancer	0.000695	0.00137	CcSEcCtD
Levosimendan—Tachycardia—Prednisone—prostate cancer	0.000691	0.00137	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000686	0.00136	CcSEcCtD
Levosimendan—Mental disorder—Epirubicin—prostate cancer	0.000683	0.00135	CcSEcCtD
Levosimendan—Constipation—Capecitabine—prostate cancer	0.00068	0.00134	CcSEcCtD
Levosimendan—Malnutrition—Epirubicin—prostate cancer	0.000679	0.00134	CcSEcCtD
Levosimendan—Diarrhoea—Etoposide—prostate cancer	0.000676	0.00134	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—prostate cancer	0.00067	0.00132	CcSEcCtD
Levosimendan—Angiopathy—Doxorubicin—prostate cancer	0.000655	0.00129	CcSEcCtD
Levosimendan—Dizziness—Etoposide—prostate cancer	0.000653	0.00129	CcSEcCtD
Levosimendan—Insomnia—Prednisone—prostate cancer	0.000641	0.00127	CcSEcCtD
Levosimendan—Mental disorder—Doxorubicin—prostate cancer	0.000632	0.00125	CcSEcCtD
Levosimendan—Vomiting—Etoposide—prostate cancer	0.000628	0.00124	CcSEcCtD
Levosimendan—Malnutrition—Doxorubicin—prostate cancer	0.000628	0.00124	CcSEcCtD
Levosimendan—Headache—Etoposide—prostate cancer	0.000619	0.00122	CcSEcCtD
Levosimendan—Constipation—Prednisone—prostate cancer	0.000606	0.0012	CcSEcCtD
Levosimendan—Nausea—Etoposide—prostate cancer	0.000587	0.00116	CcSEcCtD
Levosimendan—Diarrhoea—Docetaxel—prostate cancer	0.000562	0.00111	CcSEcCtD
Levosimendan—Diarrhoea—Capecitabine—prostate cancer	0.000544	0.00107	CcSEcCtD
Levosimendan—Nervous system disorder—Epirubicin—prostate cancer	0.000543	0.00107	CcSEcCtD
Levosimendan—Dizziness—Docetaxel—prostate cancer	0.000543	0.00107	CcSEcCtD
Levosimendan—Tachycardia—Epirubicin—prostate cancer	0.000541	0.00107	CcSEcCtD
Levosimendan—Dizziness—Capecitabine—prostate cancer	0.000526	0.00104	CcSEcCtD
Levosimendan—Vomiting—Docetaxel—prostate cancer	0.000522	0.00103	CcSEcCtD
Levosimendan—Hypotension—Epirubicin—prostate cancer	0.000518	0.00102	CcSEcCtD
Levosimendan—Headache—Docetaxel—prostate cancer	0.000514	0.00102	CcSEcCtD
Levosimendan—Vomiting—Capecitabine—prostate cancer	0.000506	0.000998	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—prostate cancer	0.000503	0.000993	CcSEcCtD
Levosimendan—Insomnia—Epirubicin—prostate cancer	0.000501	0.000989	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—prostate cancer	0.0005	0.000988	CcSEcCtD
Levosimendan—Headache—Capecitabine—prostate cancer	0.000498	0.000984	CcSEcCtD
Levosimendan—Nausea—Docetaxel—prostate cancer	0.000488	0.000963	CcSEcCtD
Levosimendan—Diarrhoea—Prednisone—prostate cancer	0.000485	0.000957	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—prostate cancer	0.000479	0.000946	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000478	0.000944	CcSEcCtD
Levosimendan—Constipation—Epirubicin—prostate cancer	0.000474	0.000935	CcSEcCtD
Levosimendan—Nausea—Capecitabine—prostate cancer	0.000472	0.000933	CcSEcCtD
Levosimendan—Dizziness—Prednisone—prostate cancer	0.000468	0.000925	CcSEcCtD
Levosimendan—Insomnia—Doxorubicin—prostate cancer	0.000464	0.000915	CcSEcCtD
Levosimendan—Vomiting—Prednisone—prostate cancer	0.00045	0.000889	CcSEcCtD
Levosimendan—Headache—Prednisone—prostate cancer	0.000444	0.000876	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000442	0.000874	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—prostate cancer	0.000438	0.000866	CcSEcCtD
Levosimendan—Nausea—Prednisone—prostate cancer	0.000421	0.000831	CcSEcCtD
Levosimendan—Diarrhoea—Epirubicin—prostate cancer	0.000379	0.000748	CcSEcCtD
Levosimendan—Dizziness—Epirubicin—prostate cancer	0.000366	0.000723	CcSEcCtD
Levosimendan—Vomiting—Epirubicin—prostate cancer	0.000352	0.000696	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—prostate cancer	0.000351	0.000693	CcSEcCtD
Levosimendan—Headache—Epirubicin—prostate cancer	0.000347	0.000685	CcSEcCtD
Levosimendan—Dizziness—Doxorubicin—prostate cancer	0.000339	0.000669	CcSEcCtD
Levosimendan—Nausea—Epirubicin—prostate cancer	0.000329	0.00065	CcSEcCtD
Levosimendan—Vomiting—Doxorubicin—prostate cancer	0.000326	0.000644	CcSEcCtD
Levosimendan—Headache—Doxorubicin—prostate cancer	0.000321	0.000634	CcSEcCtD
Levosimendan—Nausea—Doxorubicin—prostate cancer	0.000304	0.000601	CcSEcCtD
Levosimendan—PDE3A—Hemostasis—PRKCQ—prostate cancer	0.000278	0.000961	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTBP2—prostate cancer	0.000276	0.000954	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSD17B1—prostate cancer	0.000276	0.000954	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAUR—prostate cancer	0.000274	0.00095	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PDE4D—prostate cancer	0.00027	0.000934	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNRH1—prostate cancer	0.000268	0.000928	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—VIP—prostate cancer	0.000268	0.000928	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLXNB1—prostate cancer	0.000264	0.000915	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—B4GALT4—prostate cancer	0.000261	0.000902	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HPGD—prostate cancer	0.000261	0.000902	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—LPAR1—prostate cancer	0.000259	0.000898	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GRP—prostate cancer	0.000259	0.000898	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PLCB2—prostate cancer	0.000257	0.000889	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—GNG5—prostate cancer	0.000257	0.000889	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VAV3—prostate cancer	0.000255	0.000881	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRPR—prostate cancer	0.000254	0.00088	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CX3CL1—prostate cancer	0.000252	0.000872	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITPR1—prostate cancer	0.000247	0.000855	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL17RD—prostate cancer	0.000246	0.00085	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PDE4D—prostate cancer	0.000245	0.000848	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TNFRSF21—prostate cancer	0.000245	0.000848	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTAP—prostate cancer	0.000238	0.000825	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP7B1—prostate cancer	0.000238	0.000825	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—GNG5—prostate cancer	0.000233	0.000807	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT1E1—prostate cancer	0.000232	0.000804	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SRD5A1—prostate cancer	0.000232	0.000804	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PTHLH—prostate cancer	0.000224	0.000774	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACSL4—prostate cancer	0.000222	0.000767	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD17B3—prostate cancer	0.000222	0.000767	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUP—prostate cancer	0.000219	0.000758	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WNT4—prostate cancer	0.000219	0.000758	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ITGB3—prostate cancer	0.000219	0.000757	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ARG2—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PHGDH—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UMPS—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ANXA1—prostate cancer	0.00021	0.000728	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RALBP1—prostate cancer	0.000209	0.000723	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MC2R—prostate cancer	0.000209	0.000723	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LDHB—prostate cancer	0.000208	0.000721	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP3A5—prostate cancer	0.000204	0.000708	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTHLH—prostate cancer	0.000203	0.000703	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKACB—prostate cancer	0.000199	0.000688	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PDHA1—prostate cancer	0.000197	0.000684	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—UCP3—prostate cancer	0.000197	0.000684	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TCN2—prostate cancer	0.000197	0.000684	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA3—prostate cancer	0.000197	0.000684	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CALCA—prostate cancer	0.000197	0.000682	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP3CA—prostate cancer	0.000194	0.000671	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—prostate cancer	0.000193	0.000667	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—prostate cancer	0.000192	0.000666	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL12—prostate cancer	0.000192	0.000666	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ANXA1—prostate cancer	0.000191	0.000661	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD3B1—prostate cancer	0.000188	0.000652	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC22A3—prostate cancer	0.000188	0.000652	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAV1—prostate cancer	0.000188	0.000651	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PENK—prostate cancer	0.000186	0.000644	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TBXAS1—prostate cancer	0.000181	0.000625	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA4—prostate cancer	0.000181	0.000625	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALCA—prostate cancer	0.000179	0.000619	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GHR—prostate cancer	0.000178	0.000615	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA2—prostate cancer	0.000176	0.000609	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCQ—prostate cancer	0.000175	0.000607	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL12—prostate cancer	0.000175	0.000605	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT1A1—prostate cancer	0.000174	0.000602	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCG5—prostate cancer	0.000174	0.000602	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—prostate cancer	0.000171	0.000593	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRP1—prostate cancer	0.00017	0.000589	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA1—prostate cancer	0.00017	0.000588	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—prostate cancer	0.000169	0.000586	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTO1—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSD3B2—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NAT2—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—prostate cancer	0.000165	0.000571	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2C18—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCB2—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LRP2—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—VAV3—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCQ—prostate cancer	0.000159	0.000552	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CREBBP—prostate cancer	0.000159	0.00055	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VIP—prostate cancer	0.000158	0.000548	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNRH1—prostate cancer	0.000158	0.000548	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—P4HB—prostate cancer	0.000158	0.000546	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—prostate cancer	0.000157	0.000543	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ITPR1—prostate cancer	0.000156	0.00054	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC22A1—prostate cancer	0.000154	0.000532	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPAR1—prostate cancer	0.000153	0.000531	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRP—prostate cancer	0.000153	0.000531	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLCB2—prostate cancer	0.000152	0.000525	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LRP2—prostate cancer	0.000152	0.000525	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—prostate cancer	0.000151	0.000521	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—prostate cancer	0.00015	0.000519	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT2A1—prostate cancer	0.00015	0.000518	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—prostate cancer	0.000149	0.000515	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—P4HB—prostate cancer	0.000149	0.000515	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CX3CL1—prostate cancer	0.000149	0.000515	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MED12—prostate cancer	0.000147	0.00051	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—VAV3—prostate cancer	0.000146	0.000506	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000146	0.000506	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GNG5—prostate cancer	0.000146	0.000506	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRB7—prostate cancer	0.000145	0.000501	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4D—prostate cancer	0.000145	0.000501	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—prostate cancer	0.000142	0.000492	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ITPR1—prostate cancer	0.000142	0.000491	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H4H—prostate cancer	0.000141	0.000488	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA3—prostate cancer	0.000141	0.000487	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—JAK2—prostate cancer	0.000138	0.000478	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNG5—prostate cancer	0.000138	0.000477	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HPGDS—prostate cancer	0.000134	0.000465	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2C19—prostate cancer	0.000133	0.000462	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—prostate cancer	0.000131	0.000454	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACHE—prostate cancer	0.00013	0.000451	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—prostate cancer	0.00013	0.000451	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2A6—prostate cancer	0.000129	0.000445	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKR1C3—prostate cancer	0.000125	0.000433	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PRKACB—prostate cancer	0.000125	0.000431	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP17A1—prostate cancer	0.000123	0.000427	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—prostate cancer	0.00012	0.000417	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—prostate cancer	0.00012	0.000415	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR1—prostate cancer	0.00012	0.000415	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKR1C3—prostate cancer	0.000118	0.000409	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA2—prostate cancer	0.000117	0.000406	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKACB—prostate cancer	0.000117	0.000406	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—THBS1—prostate cancer	0.000114	0.000396	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP3CA—prostate cancer	0.000114	0.000396	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ANXA1—prostate cancer	0.000113	0.00039	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A5—prostate cancer	0.000112	0.000388	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCZ—prostate cancer	0.000111	0.000383	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2E1—prostate cancer	0.000109	0.000379	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—prostate cancer	0.000108	0.000375	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NQO1—prostate cancer	0.000108	0.000375	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EP300—prostate cancer	0.000108	0.000374	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PARP1—prostate cancer	0.000107	0.00037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR4—prostate cancer	0.000107	0.00037	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TH—prostate cancer	0.000107	0.000369	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALCA—prostate cancer	0.000106	0.000366	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP3A4—prostate cancer	0.000105	0.000365	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—prostate cancer	0.000105	0.000364	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1B1—prostate cancer	0.000104	0.000359	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL12—prostate cancer	0.000103	0.000357	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—prostate cancer	0.000102	0.000354	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GGT1—prostate cancer	0.0001	0.000348	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA1—prostate cancer	9.89e-05	0.000343	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—prostate cancer	9.83e-05	0.00034	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP19A1—prostate cancer	9.75e-05	0.000338	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP9—prostate cancer	9.71e-05	0.000336	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—prostate cancer	9.51e-05	0.000329	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NGFR—prostate cancer	9.41e-05	0.000326	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCQ—prostate cancer	9.41e-05	0.000326	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RXRA—prostate cancer	9.41e-05	0.000326	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—prostate cancer	9.4e-05	0.000325	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP3K7—prostate cancer	9.3e-05	0.000322	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—COMT—prostate cancer	9.07e-05	0.000314	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—prostate cancer	9.02e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF10—prostate cancer	8.94e-05	0.00031	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ITPR1—prostate cancer	8.88e-05	0.000307	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—prostate cancer	8.85e-05	0.000306	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—JAK2—prostate cancer	8.73e-05	0.000302	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—prostate cancer	8.71e-05	0.000301	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAP2K1—prostate cancer	8.7e-05	0.000301	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—prostate cancer	8.64e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VAV3—prostate cancer	8.63e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR2—prostate cancer	8.51e-05	0.000295	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMS—prostate cancer	8.39e-05	0.00029	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITPR1—prostate cancer	8.37e-05	0.00029	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—prostate cancer	8.29e-05	0.000287	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—prostate cancer	8.29e-05	0.000287	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPL—prostate cancer	8.14e-05	0.000282	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—prostate cancer	8e-05	0.000277	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—prostate cancer	8e-05	0.000277	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—prostate cancer	7.97e-05	0.000276	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—JAK2—prostate cancer	7.93e-05	0.000274	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A1—prostate cancer	7.86e-05	0.000272	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ERCC2—prostate cancer	7.8e-05	0.00027	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—prostate cancer	7.74e-05	0.000268	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPL—prostate cancer	7.67e-05	0.000266	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—prostate cancer	7.61e-05	0.000264	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFRB—prostate cancer	7.6e-05	0.000263	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—prostate cancer	7.53e-05	0.000261	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGB3—prostate cancer	7.41e-05	0.000257	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—prostate cancer	7.33e-05	0.000254	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—prostate cancer	7.24e-05	0.00025	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARA—prostate cancer	7.19e-05	0.000249	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB3—prostate cancer	7.19e-05	0.000249	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR2—prostate cancer	7.18e-05	0.000248	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—prostate cancer	6.91e-05	0.000239	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—prostate cancer	6.89e-05	0.000239	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAV1—prostate cancer	6.76e-05	0.000234	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—prostate cancer	6.59e-05	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—prostate cancer	6.53e-05	0.000226	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—prostate cancer	6.43e-05	0.000223	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CAV1—prostate cancer	6.37e-05	0.000221	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—prostate cancer	6.3e-05	0.000218	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—prostate cancer	6.16e-05	0.000213	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—prostate cancer	6.14e-05	0.000213	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BAD—prostate cancer	5.99e-05	0.000207	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—INS—prostate cancer	5.83e-05	0.000202	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—prostate cancer	5.8e-05	0.000201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—prostate cancer	5.8e-05	0.000201	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—prostate cancer	5.74e-05	0.000199	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IRS1—prostate cancer	5.74e-05	0.000199	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CREBBP—prostate cancer	5.71e-05	0.000198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GSK3B—prostate cancer	5.57e-05	0.000193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—INS—prostate cancer	5.49e-05	0.00019	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—prostate cancer	5.41e-05	0.000187	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREBBP—prostate cancer	5.38e-05	0.000186	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—prostate cancer	5.31e-05	0.000184	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—prostate cancer	5.29e-05	0.000183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAP2K1—prostate cancer	5.14e-05	0.000178	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—prostate cancer	5.11e-05	0.000177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—prostate cancer	5.1e-05	0.000177	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—prostate cancer	5.05e-05	0.000175	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—prostate cancer	5.05e-05	0.000175	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—prostate cancer	5e-05	0.000173	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF2—prostate cancer	4.89e-05	0.000169	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—prostate cancer	4.82e-05	0.000167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—prostate cancer	4.72e-05	0.000163	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAK2—prostate cancer	4.68e-05	0.000162	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—prostate cancer	4.67e-05	0.000162	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—prostate cancer	4.59e-05	0.000159	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—prostate cancer	4.57e-05	0.000158	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—prostate cancer	4.51e-05	0.000156	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—prostate cancer	4.45e-05	0.000154	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—prostate cancer	4.27e-05	0.000148	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1B—prostate cancer	4.17e-05	0.000145	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—prostate cancer	4.13e-05	0.000143	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—prostate cancer	4.09e-05	0.000142	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—prostate cancer	4.08e-05	0.000141	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—prostate cancer	4.08e-05	0.000141	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—prostate cancer	4.06e-05	0.000141	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—prostate cancer	3.98e-05	0.000138	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNB1—prostate cancer	3.94e-05	0.000137	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—EP300—prostate cancer	3.89e-05	0.000135	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—prostate cancer	3.87e-05	0.000134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—prostate cancer	3.85e-05	0.000133	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—prostate cancer	3.84e-05	0.000133	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—prostate cancer	3.75e-05	0.00013	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EP300—prostate cancer	3.67e-05	0.000127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—prostate cancer	3.56e-05	0.000123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—prostate cancer	3.47e-05	0.00012	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—prostate cancer	3.44e-05	0.000119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—prostate cancer	3.19e-05	0.000111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—prostate cancer	3.19e-05	0.00011	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—prostate cancer	3.12e-05	0.000108	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—prostate cancer	2.95e-05	0.000102	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—prostate cancer	2.88e-05	9.96e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—prostate cancer	2.71e-05	9.39e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—prostate cancer	2.62e-05	9.08e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—prostate cancer	2.4e-05	8.31e-05	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—prostate cancer	2.35e-05	8.13e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—prostate cancer	2.21e-05	7.67e-05	CbGpPWpGaD
